EP3233111
LYFJASAMSETNING SEM INNIHELDUR PLASMÍNÓGEN OG NOTKUN ÞESS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.12.2015EP published:
7.8.2024EP application number:
15868755.8
EP translation filed:
3.10.2024Grant published:
15.12.2024EPO information:
European Patent Register
Max expiry date:
17.12.2035Expiry date:
17.12.2026Next due date:
31.12.2026
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING PLASMINOGEN AND USES THEREOFLanguage of the patent:
English
Timeline
Today
18.12.2015EP application
7.8.2024EP Publication
3.10.2024Translation submitted
15.12.2024Registration published
17.12.2026Expires
Owner
Name:
Kedrion Biopharma Inc.Address:
400 Kelby Street, 11th Floor, Fort Lee, NJ 07024, US
Inventor
Name:
ROBITAILLE, MartinAddress:
Saint-Colomban, Québec J5K 1W2, CA
Name:
BLACKMAN, DavidaAddress:
Gaithersburg, MD 20878, US
Name:
PLUM, StacyAddress:
Arlington, VA 22205, US
Name:
GARZON-RODRIGUEZ, WilliamAddress:
Exton, PA 19341, US
Name:
YU, BettyAddress:
Frederick, MD 21703, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201462094556 PDate:
19.12.2014Country:
US
Classification
Categories:
A61K 9/00, A61K 47/12, A61K 47/26, A61K 9/19, A61P 1/02, A61P 9/10, A61P 7/02, A61K 38/48, A61K 47/02, A61K 47/10, A61K 47/18, C12N 9/68, A61K 9/08, A61P 17/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 22.11.2024
Expires: 17.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.12.2025
Expires: 17.12.2026
Payer: Árnason Faktor ehf.